Institutional investors purchased a net $664.3 thousand shares of GHDX during the quarter ended March 2016, and now own 92.88% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LOOMIS, SAYLES & CO. LP Bought 631.4 Thousand shares of Genomic Health Inc
ACADIAN ASSET MANAGEMENT LLC Bought 466.8 Thousand shares of Genomic Health Inc
CORTINA ASSET MANAGEMENT LLC Bought 201.1 Thousand shares of Genomic Health Inc